Fig 4.
HLA-B*2705 stabilization assay with synthetic VACV ligands. (A) Stability of HLA-B*2705-peptide complexes on the surface of RMA-S transfectant cells measured by flow cytometry. The indicated peptides were used at 200 μM. The mAb used was ME1. (B) The titration curves for synthetic VACV A10L867-876, K2L16-30, and B8R53-59 peptides with HLA-B*2705 are depicted. The C4CON and influenza virus (Flu) NP peptides were used as negative and positive controls, respectively. The results, as in Fig. 2, represent the means of the results of four independent experiments.